Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi.
The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new project is funded by Unitaid through a grant of almost US$ 14 million and will be implemented in five different countries (Ethiopia, Tanzania, the Philippines, South Africa and Ukraine). It will support TB patients during their treatment with digital adherence technologies. These groundbreaking innovations have great added value for both patients and caregivers.
The 10th IAS Conference on HIV Science – known as IAS 2019 – will take place on 21-24 July 2019 in Mexico City, Mexico. The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational research that moves science into policy and practice. Through its open and inclusive programme development, the meeting sets the gold standard of HIV research featuring highly diverse and cutting-edge studies.
JOHANNESBERG, SOUTH AFRICA - An innovative system to dispense medicine to patients with chronic illnesses is taking off in South Africa. The award-winning “Pelebox,” created by South African engineer Neo Hutiri, is a computer-controlled vending machine stocked with prescription drugs, which patients
access using a personal code.
DURBAN (South Africa) 13 June 2019 – A pivotal clinical trial to address a long-standing question about the relationship between hormonal contraceptive use and the risk of HIV acquisition has found no substantial difference in HIV risk among 7,829 African women who were randomly assigned to use one of three highly effective methods of contraception.